These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37667103)

  • 1. Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing.
    Fratoni AJ; Berry AV; Liu X; Chen X; Wu Y; Nicolau DP; Abdelraouf K
    J Antimicrob Chemother; 2023 Sep; 78(9):2343-2353. PubMed ID: 37667103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of a novel β-lactamase inhibitor combination imipenem/XNW4107 against recent clinical Gram-negative bacilli from China.
    Li Y; Yan M; Xue F; Zhong W; Liu X; Chen X; Wu Y; Zhang J; Wang Q; Zheng B; Lv Y
    J Glob Antimicrob Resist; 2022 Dec; 31():1-9. PubMed ID: 35820591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria.
    Abdelraouf K; Almarzoky Abuhussain S; Nicolau DP
    J Antimicrob Chemother; 2020 Dec; 75(12):3601-3610. PubMed ID: 32862218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model.
    Gill CM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2021 Mar; 76(4):993-1000. PubMed ID: 33438033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of human-simulated regimens of imipenem alone and in combination with relebactam against Pseudomonas aeruginosa in the murine thigh infection model.
    Reyes S; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2020 Aug; 75(8):2197-2205. PubMed ID: 32386408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept.
    Igarashi Y; Takemura W; Liu X; Kojima N; Morita T; Chuang VTG; Enoki Y; Taguchi K; Matsumoto K
    Pharm Res; 2023 Oct; 40(10):2423-2431. PubMed ID: 37783926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model.
    Mavridou E; Melchers RJ; van Mil AC; Mangin E; Motyl MR; Mouton JW
    Antimicrob Agents Chemother; 2015 Feb; 59(2):790-5. PubMed ID: 25403667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model.
    Bulik CC; Christensen H; Li P; Sutherland CA; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2010 Feb; 54(2):804-10. PubMed ID: 19995927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models.
    Muller AE; Raaphorst M; van der Meijden A; de Winter BCM; Meletiadis J; van den Berg S
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0143322. PubMed ID: 36692307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
    Kuti JL; Florea NR; Nightingale CH; Nicolau DP
    Pharmacotherapy; 2004 Jan; 24(1):8-15. PubMed ID: 14740783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model.
    Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2023 Mar; 78(3):692-702. PubMed ID: 36640133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy and PK/PD analyses of zifanocycline (KBP-7072), an aminomethylcycline antibiotic, against Acinetobacter baumannii in a neutropenic murine thigh infection model.
    Li L; Tan X; Zhou T; Chi S; Zhu Y; Liu Q; Chen Y; Zhang J
    J Infect Chemother; 2024 Jan; 30(1):34-39. PubMed ID: 37714267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1665-70. PubMed ID: 12019073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.